First Patient Injected With Experimental Cancer-Killing Virus in New Clinical Trial
Https://www.sciencealert.com/first-patient-injected-with-experimental-cancer-killing-virus-in-new-clinical-trial
Stay updated with breaking news from Daneng Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Https://www.sciencealert.com/first-patient-injected-with-experimental-cancer-killing-virus-in-new-clinical-trial
Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors.
A clinical trial led by researchers at City of Hope, a world-renowned cancer research and treatment organization, showed that patients over 65 receiving chemotherapy experienced significantly fewer treatment-related side effects when a multidisciplinary team of experts analyzed each case and introduced personalized interventions.